Abstract
Fludarabine, the 5'-monophosphate of 9-beta-D-arabinofuranosyl-2- fluoroadenine (FaraAMP), is effective in the treatment of chronic lymphocytic leukemia (CLL) and has been demonstrated to increase natural killer (NK) cell lytic activity (NKa) in humans and mice. To determine the effect of FaraAMP on NK cells in CLL, we analyzed NKa toward K562 targets after in vitro incubation with FaraAMP and after in vivo exposure to fludarabine. Pretreatment analysis of peripheral blood from 12 CLL patients (9 untreated) revealed: median number of NK cells 500/microliter (range 290-1160); median NKa lytic unit30/10(6) cells (range 5-80). These results were similar to those from healthy adult donors. After exposure to 3, 30 or 300 microM FaraAMP, the median maximum stimulation index (NKa FaraAMP/NKa) was 1.2 (range 0.9-1.5), within the range observed in normal adults. FaraA also stimulated NKa in vitro toward autologous CLL cells in two of five patients as measured by a dye-exclusion assay. In three patients following three or more treatment courses of fludarabine (30 mg/m2 per day for 5 days) the NK cell number and NKa were maintained near pretreatment values. Phenotypic analysis of the peripheral mononuclear cells in 34 consecutive CLL pati...Continue Reading
References
May 11, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R RedmanM J Keating
Sep 1, 1990·Cellular Immunology·T PriebeJ A Nelson
Oct 15, 1990·Cellular Immunology·T PriebeJ A Nelson
Jan 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J KeatingK B McCredie
Jan 1, 1990·European Journal of Haematology·A ApostolopoulosN Zoumbos
Jul 1, 1989·American Journal of Hematology·R T Perri, N E Kay
Feb 1, 1987·Immunopharmacology·R W LuebkeR J Smialowicz
Feb 1, 1987·American Journal of Hematology·N E Kay, J Zarling
Nov 1, 1988·American Journal of Hematology·B D ChesonS J Kempin
Jan 1, 1986·British Journal of Haematology·R FoaF Lauria
Jan 1, 1985·Annals of the New York Academy of Sciences·J E Seegmiller
Nov 18, 1972·Lancet·E R GiblettH J Meuwissen
Mar 15, 1981·International Journal of Cancer. Journal International Du Cancer·H W ZieglerJ M Zarling
Nov 1, 1984·British Journal of Haematology·R FoaL Matera
Jan 1, 1994·European Journal of Haematology·F LauriaS Tura
Citations
Sep 11, 2008·Cancer Chemotherapy and Pharmacology·Erica L WoodahlJeannine S McCune
Oct 15, 2005·Leukemia·U SieglerA Wodnar-Filipowicz
Jul 27, 2001·British Journal of Haematology·M W LowdellH G Prentice
Jun 13, 2002·British Journal of Haematology·Mark W LowdellH Grant Prentice
Apr 18, 2000·Journal of Clinical Pathology·M W Lowdell, M B Koh
May 24, 2008·Blood·Mohammad LuqmanAnas Younes
Feb 2, 2010·Immunology and Allergy Clinics of North America·Christopher C Dvorak, Morton J Cowan
Jun 10, 2015·The Journal of Allergy and Clinical Immunology·Morton J Cowan, Andrew R Gennery
Dec 5, 2003·Transfusion Medicine·M W Lowdell
Jul 1, 2014·Pediatric Transplantation·Christopher C DvorakMorton J Cowan
May 20, 2015·Cancer Chemotherapy and Pharmacology·Jeannine S McCuneShelly Heimfeld
Sep 23, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christopher C DvorakMorton J Cowan
Mar 31, 2015·Current Pediatrics Reports·Justin T WahlstromMorton J Cowan
Sep 14, 2016·Oncoimmunology·Veit BückleinElfriede Noessner
May 10, 2016·ACS Chemical Biology·Somsinee WisitpitthayaYimon Aye
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S CzuczmanS H Bernstein
Jan 1, 1997·Hematology·M W LowdellH G Prentice
Jun 14, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Cristina F ContrerasChristopher C Dvorak